President Trump's executive order on drug pricing fuels debate, potentially reshaping U.S. healthcare economics and impacting the biotech industry. The directive proposes significant cuts in Medicaid drug reimbursements, posing a…
Sam Waksal is embroiled in a legal controversy involving the clandestine import of an illicit veterinary drug, allegedly used in an unauthorized trial for Equilibre Biopharmaceuticals. A whistleblower exposes Waksal…
Digital platforms are enhancing scrutiny over account activity to combat misuse by bots and automated intrusions. Accessing more than 85 pages in 24 hours via automated means triggers security measures,…
Peter J. Weiler takes over as CFO of Edesa Biotech, starting May 1, 2025, bringing extensive biotech industry experience. The transition aims to enhance Edesa's financial strategies and align them…
Jill Angelo transitions from Unified Women’s Healthcare, leaving a legacy in menopause health awareness and telehealth services with Gennev. Aurion Biotech advances in cell therapies for eye diseases, bolstered by…
The partnership between Emergent BioSolutions and Rocketvax drives innovation in global health, focusing on vaccine development for infectious diseases, cancer, and autoimmune disorders. Rocketvax's live-attenuated nasal spray SARS-CoV-2 vaccine exhibits…
Colossal Biosciences aims to resurrect the woolly mammoth, extinct for millennia, potentially being the first de-extinct species brought back by 2028. The "woolly mouse," engineered with mammoth genes, exhibits traits…
IPOs offer lucrative investment opportunities in the public market. Expert guidance, like that from Donovan Jones at IPO Edge, can reveal valuable insights. Accessing IPO filings and calendars is crucial…
**A rough year for BRAIN Biotech has resulted in declining revenue and increasing net losses.** The company reported a revenue of €55.5 million for the fiscal year, reflecting a minor…
### Major Startup Funding Highlights This Week Investors are making waves in the startup ecosystem as 2024 starts off strong with significant funding rounds. This week continues to showcase major…